Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ongavia 2.3mg/0.23ml solution for injection vials
1108020ADBCAAAB
|
Ongavia | Ranibizumab | Eye | 1 |
|
Byooviz 2.3mg/0.23ml solution for injection vials
1108020ADBDAAAB
|
Byooviz | Ranibizumab | Eye | No data available |
|
Lucentis 1.65mg/0.165ml inj pre-filled syringes
1108020ADBBACAC
|
Lucentis | Ranibizumab | Eye | No data available |
|
Lucentis 2.3mg/0.23ml solution for injection vials
1108020ADBBABAB
|
Lucentis | Ranibizumab | Eye | No data available |
|
Lucentis 3mg/0.3ml solution for injection vials
1108020ADBBAAAA
|
Lucentis | Ranibizumab | Eye | No data available |
|
Ranibizumab 1.65mg/0.165ml inj pre-filled syringes
1108020ADAAACAC
|
Ranibizumab | Ranibizumab | Eye | No data available |
|
Ranibizumab 2.3mg/0.23ml solution for injection vials
1108020ADAAABAB
|
Ranibizumab | Ranibizumab | Eye | No data available |
|
Ranibizumab 3mg/0.3ml solution for injection vials
1108020ADAAAAAA
|
Ranibizumab | Ranibizumab | Eye | No data available |
|
Ranivisio 2.3mg/0.23ml solution for injection vials
1108020ADBFAAAB
|
Ranivisio | Ranibizumab | Eye | No data available |
|
Rimmyrah 2.3mg/0.23ml solution for injection vials
1108020ADBGAAAB
|
Rimmyrah | Ranibizumab | Eye | No data available |
|
Ximluci 2.3mg/0.23ml solution for injection vials
1108020ADBEAAAB
|
Ximluci | Ranibizumab | Eye | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.